Hongyun Lian

678 total citations
50 papers, 330 citations indexed

About

Hongyun Lian is a scholar working on Infectious Diseases, Physiology and Hematology. According to data from OpenAlex, Hongyun Lian has authored 50 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 22 papers in Physiology and 21 papers in Hematology. Recurrent topics in Hongyun Lian's work include Parvovirus B19 Infection Studies (26 papers), Histiocytic Disorders and Treatments (22 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). Hongyun Lian is often cited by papers focused on Parvovirus B19 Infection Studies (26 papers), Histiocytic Disorders and Treatments (22 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). Hongyun Lian collaborates with scholars based in China, Russia and United States. Hongyun Lian's co-authors include Honghao Ma, Zhigang Li, Yunze Zhao, Dong Wang, Rui Zhang, Li Zhang, Qing Zhang, Ang Wei, Lei Cui and Tianyou Wang and has published in prestigious journals such as The Journal of Infectious Diseases, The Journal of Pediatrics and Medicine.

In The Last Decade

Hongyun Lian

43 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyun Lian China 10 177 150 142 97 76 50 330
Olive S. Eckstein United States 9 242 1.4× 162 1.1× 175 1.2× 112 1.2× 65 0.9× 29 411
Ang Wei China 10 178 1.0× 154 1.0× 121 0.9× 43 0.4× 40 0.5× 38 275
Monika Trebo Austria 8 124 0.7× 61 0.4× 67 0.5× 77 0.8× 57 0.8× 16 270
Maria Luisa Coniglio Italy 9 168 0.9× 168 1.1× 89 0.6× 20 0.2× 17 0.2× 19 279
Hidekazu Masuoka Japan 7 219 1.2× 104 0.7× 85 0.6× 14 0.1× 18 0.2× 23 267
L. Puig Spain 8 45 0.3× 208 1.4× 57 0.4× 30 0.3× 17 0.2× 18 320
Zebin Luo China 9 128 0.7× 75 0.5× 62 0.4× 18 0.2× 13 0.2× 30 254
Shusaku Fukaya Japan 5 203 1.1× 146 1.0× 116 0.8× 18 0.2× 46 0.6× 16 290
Junqing Mao China 5 156 0.9× 127 0.8× 82 0.6× 6 0.1× 32 0.4× 22 296
Aarati Rao United States 6 163 0.9× 160 1.1× 20 0.1× 27 0.3× 31 0.4× 10 346

Countries citing papers authored by Hongyun Lian

Since Specialization
Citations

This map shows the geographic impact of Hongyun Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyun Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyun Lian more than expected).

Fields of papers citing papers by Hongyun Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyun Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyun Lian. The network helps show where Hongyun Lian may publish in the future.

Co-authorship network of co-authors of Hongyun Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyun Lian. A scholar is included among the top collaborators of Hongyun Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyun Lian. Hongyun Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chanjuan, Lei Cui, Shuangshuang Li, et al.. (2024). Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell Histiocytosis. Archives of Pathology & Laboratory Medicine. 149(2). 175–190. 3 indexed citations
2.
Lian, Hongyun, Weijing Li, Qing Zhang, et al.. (2024). The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis. Jornal de Pediatria. 101(2). 194–201.
3.
Wang, Dong, Jian Ge, Yunze Zhao, et al.. (2024). Ruxolitinib‐based regimen in children with autoimmune disease or autoinflammatory disease‐related haemophagocytic lymphohistiocytosis. British Journal of Haematology. 206(1). 215–223. 5 indexed citations
4.
Zhu, Ting, Hongyun Lian, Honghao Ma, et al.. (2024). The plasma‐soluble CSF1R level is a promising prognostic indicator for pediatric Langerhans cell histiocytosis. Pediatric Blood & Cancer. 71(6). e30970–e30970.
5.
6.
Lian, Hongyun, Honghao Ma, Lei Cui, et al.. (2024). Clinical features and treatment outcomes of liver involvement in paediatric Langerhans cell histiocytosis. BMC Pediatrics. 24(1). 316–316. 2 indexed citations
7.
Zhao, Yunze, Ang Wei, Honghao Ma, et al.. (2023). Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis. Annals of Hematology. 102(4). 729–739. 12 indexed citations
8.
Ge, Jian, Qing Zhang, Honghao Ma, et al.. (2023). Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis. Haematologica. 109(2). 458–465. 15 indexed citations
9.
Cui, Lei, Hongyun Lian, Li Zhang, et al.. (2023). Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH‐LCH 2014 protocol study. American Journal of Hematology. 98(4). 598–607. 16 indexed citations
10.
Wang, Chanjuan, Lei Cui, Honghao Ma, et al.. (2021). BRAF V600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis. Molecular Cancer Therapeutics. 20(7). 1316–1323. 4 indexed citations
11.
Wei, Ang, Honghao Ma, Liping Zhang, et al.. (2021). Clinical analysis of chronic active EBV infection with coronary artery dilatation and a matched case–control study. Orphanet Journal of Rare Diseases. 16(1). 50–50. 6 indexed citations
12.
Zhao, Xiaoxi, Hongyun Lian, Li Zhang, et al.. (2021). Significance of serum Th1/Th2 cytokine levels in underlying disease classification of childhood HLH. Cytokine. 149. 155729–155729. 8 indexed citations
13.
Chen, Sitong, Ang Wei, Honghao Ma, et al.. (2021). Clinical Features and Prognostic Factors of Children with Chronic Active Epstein-Barr Virus Infection: A Retrospective Analysis of a Single Center. The Journal of Pediatrics. 238. 268–274.e2. 7 indexed citations
14.
Lian, Hongyun, Ang Wei, Lejian He, et al.. (2021). Clinical Analysis of Pediatric Systemic Juvenile Xanthogranulomas: A Retrospective Single-Center Study. Frontiers in Pediatrics. 9. 672547–672547. 4 indexed citations
15.
Yang, Ying, Chanjuan Wang, Dong Wang, et al.. (2021). Clinical study of MAP2K1-mutated Langerhans cell histiocytosis in children. Journal of Cancer Research and Clinical Oncology. 148(9). 2517–2527. 3 indexed citations
16.
Li, Na, Lei Cui, Honghao Ma, et al.. (2020). Osteopontin is highly secreted in the cerebrospinal fluid of patient with posterior pituitary involvement in Langerhans cell histiocytosis. International Journal of Laboratory Hematology. 42(6). 788–795. 5 indexed citations
17.
Zhang, Qing, Ang Wei, Honghao Ma, et al.. (2020). A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis. Haematologica. 106(7). 1892–1901. 43 indexed citations
18.
Lian, Hongyun, Li Zhang, Zhigang Li, et al.. (2019). Clinical analysis of pediatric Langerhans cell histiocytosis with craniofacial bone involvement. Zhonghua shiyong erke linchuang zazhi. 34(15). 1151–1155. 1 indexed citations
19.
Zhao, Yunze, Qing Zhang, Zhigang Li, et al.. (2018). Central Nervous System Involvement in 179 Chinese Children with Hemophagocytic Lymphohistiocytosis. Chinese Medical Journal. 131(15). 1786–1792. 17 indexed citations
20.
Cui, Chuanliang, et al.. (2008). [Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].. PubMed. 27(8). 845–50. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olive S. Eckstein Breakdown of academic impact, for papers by Ang Wei Breakdown of academic impact, for papers by Monika Trebo Breakdown of academic impact, for papers by Maria Luisa Coniglio Breakdown of academic impact, for papers by Hidekazu Masuoka Breakdown of academic impact, for papers by L. Puig Breakdown of academic impact, for papers by Zebin Luo Breakdown of academic impact, for papers by Shusaku Fukaya Breakdown of academic impact, for papers by Junqing Mao Breakdown of academic impact, for papers by Aarati Rao
Rankless by CCL
2026